title: Effects of substitutive therapy on right ventricular systolic and diastolic functions in patients with idiopathic hypogonadotropic hypogonadism.
abstract: BACKGROUND
  There have been controversial studies evaluating ventricular functions in patients with idiopathic hypogonadotropic hypogonadism (IHH). A recent study has demonstrated that low serum testosterone levels are associated with increased cardiovascular mortality.
  
  
  OBJECTIVE
  We aimed to investigate ventricular functions by standard echocardiography and examine the effects of substitutive therapy on right ventricular (RV) functions in patients with IHH by means of pulsed wave tissue Doppler imaging (PWTDI).
  
  
  METHODS
  Twenty-three patients with IHH and 31 controls were evaluated by standard echocardiography and PWTDI. Isovolumic acceleration (IVA), myocardial systolic wave (Sm) velocity, myocardial precontraction time (PCTm), and PCTm to contraction time (CTm) ratio were determined as systolic indices. Myocardial relaxation time (RTm), early (Em) velocity, late (Am) velocity, and Em to Am ratio were determined as diastolic indices.
  
  
  RESULTS
  Peak pulmonary artery pressure (PAP) was significantly higher in control subjects (p=0.008). IVA and Sm values were similar in patients and controls. Em, Am velocities, and their ratios did not differ. PCTm was significantly longer (p=0.001) and PCTm to CTm ratio was significantly higher in patients (p=0.001). These parameters also decreased after replacement therapy, albeit not statistically significantly (p>0.05). PAP was significantly higher after substitutive therapy (p=0.009).
  
  
  CONCLUSIONS
  Ventricular functions are normal in patients with IHH. Substitutive therapy has no effects on RV functions. However, substitutive therapy may increase PAP in small amounts, which has no immediate clinical implication with short-term use.
authors.affiliation: Department of Cardiology, Faculty of Medicine, Pamukkale University, Denizli, Turkey. yaylalimd@gmail.com
authors.forename: Y T
authors.initials: YT
authors.lastname: Yaylali
authors.forename: G
authors.initials: G
authors.lastname: Fidan Yaylali
authors.forename: F
authors.initials: F
authors.lastname: Akin
authors.forename: I
authors.initials: I
authors.lastname: Susam
authors.forename: M
authors.initials: M
authors.lastname: Bastemir
mesh_terms: D000328:Adult; D003971:Diastole / Q000187:drug effects / Q000502:physiology*; D004452:Echocardiography; D020249:Hormone Replacement Therapy; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy* / Q000503:physiopathology*; D008297:Male; D013599:Systole / Q000187:drug effects / Q000502:physiology*; D013739:Testosterone / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D016278:Ventricular Function, Right / Q000187:drug effects / Q000502:physiology*; D055815:Young Adult
chemical_list: D013739:Testosterone
references.citation: J Am Soc Echocardiogr. 2004 Apr;17(4):332-7
references.pmid: 15044866
references.citation: J Endocrinol Invest. 2009 Oct;32(9):718-23
references.pmid: 19535892
references.citation: Int J Sports Med. 2003 Jul;24(5):344-51
references.pmid: 12868045
references.citation: Rev Prat. 1999 Jun 15;49(12):1283-9
references.pmid: 10488659
references.citation: Cardiology. 1997 Mar-Apr;88(2):218-20
references.pmid: 9096926
references.citation: J Reprod Med. 2001 Aug;46(8):709-11
references.pmid: 11547643
references.citation: Am J Cardiol. 2005 Dec 26;96(12B):67M-72M
references.pmid: 16387571
references.citation: J Am Soc Echocardiogr. 1991 Mar-Apr;4(2):131-9
references.pmid: 2036225
references.citation: Eur Heart J. 2001 Feb;22(4):340-8
references.pmid: 11161953
references.citation: Circulation. 1984 Oct;70(4):657-62
references.pmid: 6478568
references.citation: Anim Reprod Sci. 2008 Oct;108(1-2):1-12
references.pmid: 17723281
references.citation: J Am Soc Echocardiogr. 2000 Mar;13(3):194-204
references.pmid: 10708468
references.citation: Curr Opin Cardiol. 2004 Sep;19(5):458-63
references.pmid: 15316453
references.citation: Clin Endocrinol (Oxf). 2007 Feb;66(2):235-45
references.pmid: 17223994
references.citation: Horm Metab Res. 2001 Nov;33(11):645-52
references.pmid: 11733866
references.citation: Circulation. 2002 Apr 9;105(14):1693-9
references.pmid: 11940549
references.citation: N Engl J Med. 2007 Aug 30;357(9):863-73
references.pmid: 17761590
references.citation: Echocardiography. 2007 Mar;24(3):222-7
references.pmid: 17313632
references.citation: J Am Soc Echocardiogr. 1989 Sep-Oct;2(5):358-67
references.pmid: 2698218
references.citation: J Clin Invest. 1996 Oct 15;98(8):1699-702
references.pmid: 8878418
references.citation: J Cardiovasc Pharmacol. 2002 Jun;39(6):814-23
references.pmid: 12021575
references.citation: J Am Coll Cardiol. 1987 Mar;9(3):549-54
references.pmid: 3546460
references.citation: Am J Cardiol. 1998 Aug 1;82(3):352-7
references.pmid: 9708666
references.citation: Int J Sports Med. 2003 Jul;24(5):337-43
references.pmid: 12868044
references.citation: J Am Soc Echocardiogr. 1989 May-Jun;2(3):157-71
references.pmid: 2627428
references.citation: J Mol Cell Cardiol. 2003 Jul;35(7):761-7
references.pmid: 12818566
references.citation: J Am Coll Cardiol. 1985 Aug;6(2):359-65
references.pmid: 4019921
references.citation: N Engl J Med. 1999 Jan 14;340(2):115-26
references.pmid: 9887164
references.citation: Eur Heart J. 1996 Oct;17(10):1576-83
references.pmid: 8909917
references.citation: Am J Cardiol. 1990 Aug 15;66(4):493-6
references.pmid: 2386120
references.citation: Am J Physiol Endocrinol Metab. 2003 Sep;285(3):E449-53
references.pmid: 12684218
references.citation: Curr Opin Cardiol. 2004 Sep;19(5):421-9
references.pmid: 15316447
references.citation: J Am Soc Echocardiogr. 1999 Aug;12(8):618-28
references.pmid: 10441217
references.citation: Circulation. 1978 Dec;58(6):1072-83
references.pmid: 709763
references.citation: Pituitary. 2010 Jun;13(2):105-10
references.pmid: 19838805
references.citation: Eur Heart J. 2010 Jun;31(12):1494-501
references.pmid: 20164245